Regeneron Pharmaceuticals said a key late-stage melanoma study failed, adding to a series of challenges for the US biotech https://t.co/Jf0ZwD7vea ...

From the America Innovates stage, Timothy Springer, biotech founder, investor, and honoree on the Forbes 250 America’s Greatest Living Innovators list, on the medical advances helping keep cancer patients alive.⠀#Forbes250 #A250 https://t.co/i1pNzY2fJJ ...